Anti-type 1 interferon receptor subunit 1 monoclonal antibody: Anifrolumab

Authors

Shunichiro Takezaki (ORCID: https://orcid.org/0000-0002-0425-4097)

Institutions

NTT Medical Center (JP)

Publication Details

Journal: Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology
Published: 2024-08-19
DOI: https://doi.org/10.3388/jspaci.38.306
Primary Topic: Systemic Lupus Erythematosus Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Anti-type 1 interferon receptor subunit 1 monoclonal antibody: Anifrolumab

Shunichiro Takezaki

Aug 19, 2024

Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology

Systemic Lupus Erythematosus Research

article

Anti-type 1 interferon receptor subunit 1 monoclonal antibody: Anifrolumab

Shunichiro Takezaki

August 19, 2024article en

Abstract

No abstract available for this paper.

Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical ImmunologyVol. 38(3)

NTT Medical Center (JP)

Openalex Percentile: Top 75%

Systemic Lupus Erythematosus Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Anti-type 1 interferon receptor subunit 1 monoclonal antibody: Anifrolumab — Shunichiro Takezaki · Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology (2024) | TGRS Research Map | TGRS